APPARATUS AND METHOD FOR DETERMINING PROGNOSIS OF BREAST CANCER AND WHETHER TO USE CHEMOTHERAPY

The present invention relates to an apparatus and method for determining the prognosis of breast cancer and whether to use chemotherapy and, more specifically, to an apparatus and method capable of predicting a necessary prognosis and chemotherapeutic effects in determining the cancer treatment direction for breast cancer using progesterone receptor immunostaining results and Ki67 protein immunostaining results. The method for determining the prognosis of breast cancer of the present invention can be performed at lower costs compared with a conventional method for determining the prognosis of breast cancer, and can provide a normalized index in predicting the prognosis of breast cancer and the chemotherapeutic effect due to relatively high accuracy, and thus finally can contribute to the improvement in national health and welfare. 本发明涉及种用于测定乳腺癌预后以及是否使用化疗的装置和方法，更具体地，涉及种能够利用孕酮受体的免疫染色结果和Ki67蛋白的免疫染色结果，在确定乳腺癌的肿瘤治疗方向中预测必要的预后和化疗效果的装置和方法。与用于测定乳腺癌预后的常规方法相比，本发明的测定乳腺癌预后的方法可以低成本进行，并且由于其相对高的准确性，能够提供用于预测乳腺癌预后和化疗效果的标准化指标，最终